News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
111 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26337)
Month
January (2946)
February (2976)
March (2715)
April (2913)
May (3635)
June (2418)
July (2095)
August (2650)
September (2453)
October (1536)
Day
1 (52)
2 (69)
3 (219)
4 (184)
5 (112)
8 (114)
9 (128)
10 (135)
11 (96)
12 (60)
15 (72)
16 (117)
17 (117)
18 (177)
19 (61)
21 (1)
22 (84)
23 (142)
24 (78)
25 (139)
26 (83)
28 (7)
29 (111)
30 (95)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
21
22
23
24
25
26
28
29
30
Press Releases
Enanta Pharmaceuticals to Present Topline Results from its Phase 2b Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
September 29, 2025
·
1 min read
Press Releases
PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
September 29, 2025
·
3 min read
Press Releases
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
September 29, 2025
·
1 min read
Press Releases
Hundreds Attend IRA Implementation Summit; Uncertainties, Confusion and Concerns About Service Levels Underscore Dialogue
September 29, 2025
·
2 min read
Press Releases
Avenzo Therapeutics Honored by Goldman Sachs for Entrepreneurship
September 29, 2025
·
3 min read
Press Releases
ME Therapeutics Secures U.S. Patent for Lead Candidate and Advances Broader Therapeutic Programs
September 29, 2025
·
5 min read
Press Releases
Shape Therapeutics Announces Multiple Oral Presentations at the European Society of Gene & Cell Therapy 32nd Annual Congress
September 29, 2025
·
1 min read
Press Releases
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
September 29, 2025
·
17 min read
Press Releases
bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung
September 29, 2025
·
6 min read
Press Releases
Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025
September 29, 2025
·
6 min read
Previous
2 of 12
Next